author-photo

Alfonso Arrazate

Genentech

10

Papers

118

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Erratum: Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer (eLife (2016) 5 PII: e44851)

2019 eLife
Show All
- Source
- Cite
- Save
Citations (2)
IFNγ-induced Chemokines Are Required for CXCR3-mediated T-Cell Recruitment and Antitumor Efficacy of Anti-HER2/CD3 Bispecific Antibody

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (19)
Abstract PD4-14: GDC-0077 is a selective PI3Kalpha inhibitor that demonstrates robust efficacy in PIK3CA mutant breast cancer models as a single agent and in combination with standard of care therapies

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (12)
Abstract 156: Preclinical characterization of GDC-0077, a specific PI3K alpha inhibitor in early clinical development

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (8)
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

2016 eLife
Show All
- Source
- Cite
- Save
Citations (68)
Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity

2014 Nanoscale Research Letters
Show All
- Source
- Cite
- Save
Citations (7)
368 GDC-0068, a Novel and Selective Akt Inhibitor Demonstrates Improvement in Anti-tumor Activity When Combined with Androgen Receptor Pathway Antagonists, MDV3100 and Abiraterone, in Prostate Cancer Models

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 873: Combined targeting of Akt and MEK with the Akt inhibitor GDC-0068 and MEK inhibitor GDC-0973 demonstrates synergistic anti-tumor effects

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)